# ClinicalTrials.gov record NCT07018544

> PeptideScanner retained ClinicalTrials.gov record NCT07018544 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was semaglutide.

- Evidence object: `story:clinicaltrials-gov-nct07018544-semaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-06-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07018544-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07018544-semaglutide-v1.json
- Content SHA-256: `b45d2dfb1d668161a7ac92a564dfdf61e981ae1f70924a021b32489238721caf`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07018544 ([`ctg-observation-nct07018544-2025-06-12-d4e76dbc7507`](#source-ctg-observation-nct07018544-2025-06-12-d4e76dbc7507))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07018544 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct07018544-2025-06-12-d4e76dbc7507`](#source-ctg-observation-nct07018544-2025-06-12-d4e76dbc7507))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07018544 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct07018544-2025-06-12-d4e76dbc7507`](#source-ctg-observation-nct07018544-2025-06-12-d4e76dbc7507))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07018544-2025-06-12-d4e76dbc7507`](#source-ctg-observation-nct07018544-2025-06-12-d4e76dbc7507))

## Sources

<a id="source-ctg-observation-nct07018544-2025-06-12-d4e76dbc7507"></a>
- **ClinicalTrials.gov record NCT07018544 · retained source version 2025-06-12:d4e76dbc750712a1bb2b9eddc12c53604e6984771e564f1e87b7f8e2d391e34f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07018544) (`ctg-observation-nct07018544-2025-06-12-d4e76dbc7507`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07018544." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07018544-semaglutide-v1.json SHA-256: b45d2dfb1d668161a7ac92a564dfdf61e981ae1f70924a021b32489238721caf.